Synthesis and Biological Evaluations of Cytotoxic and Antiangiogenic Triterpenoids-Jacaranone Conjugates

Hua Sun, Partick Y K Yue, Shao-Rong Wang

  • 1State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Xian Nong Tan Street, Beijing, 100050, China. wfang@imm.ac.cn.

Abstract

Insights

New bifunctional conjugates combine antiangiogenic and cytotoxic agents, showing enhanced potency against melanoma cells. These dual-action compounds offer a promising strategy for improved cancer therapy.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Research

Background:

  • Antiangiogenic agents offer a selective and effective approach to cancer treatment.
  • Combining antiangiogenic and cytotoxic agents can improve chemotherapy efficacy and reduce toxicity.
  • Bifunctional molecule conjugation is a rational design strategy for co-administering anticancer drugs.

Purpose of the Study:

  • To synthesize conjugates of an antiangiogenic triterpene (3-oxo oleanolic acid) and a cytotoxic semibenzoquinone (jacaranone).
  • To evaluate the cytotoxic, antiproliferative, and antiangiogenic activities of the synthesized conjugates and their parent molecules.
  • To predict potential biological targets of the conjugates using the Similarity Ensemble Approach (SEA).

Main Methods:

  • Synthesis of bifunctional conjugates linking 3-oxo oleanolic acid derivatives with jacaranone.
  • In vitro assays to determine cytotoxic, antiproliferative, and antiangiogenic activities.
  • Computational target prediction using the Similarity Ensemble Approach (SEA).

Main Results:

  • Conjugates demonstrated enhanced cytotoxic and antiangiogenic potency compared to parent molecules.
  • Conjugates exhibited selective activity against melanoma cell lines (B16 and B16BL6) over other tested cancer cell lines.
  • Predicted targets for antiangiogenesis included glycogen phosphorylase, neuraminidase, interferon gamma, and tubulin beta chain.

Conclusions:

  • Bifunctional conjugates act as dual-acting antitumor and antiangiogenic agents.
  • These novel conjugates represent a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
104
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K